The CM from IFN-γ/β-glucan-educated MPE-Mφ showed higher anti-cancer effect than the IFN-γ/β-glucan-treated control (47.08% vs. 78.93%, p < 0.001, when IFN-γ was at 12.5 ng/ml). The gene discussed is IFNG; the disease is cancer.